Skip to main content

Drugs for the Treatment of Inflammatory and Autoimmune Disease

  • Chapter
Immunopharmacology Reviews Volume 2

Abstract

Drugs that are used to treat acute and chronic inflammatory disorders suppress natural processes that contribute to the signs and symptoms of inflammation. Drugs that are used to treat simple forms of arthritis such as gout and osteoarthritis relieve pain and swelling and improve mobility. These agents are often referred to as nonsteroidal antiinflammatory drugs (NSAIDs). In the absence of known infection, chronic inflammation with strong immune components is termed autoimmune. Drugs that are used to treat autoimmune arthritides such as rheumatoid arthritis and the reactive arthritides (psoriatic arthritis and Reiter’s syndrome) act not only to suppress inflammation but also to modify the disease process by impairing the expression of the immune components of the inflammation. These latter drugs are often referred to as disease-modifying antirheumatic drugs (DMARDs). DMARDs can act as immunomodulators or as immunosuppressive agents. Autoimmune disorders without attendant inflammation are generally treated with immunosuppressive drugs alone. Antiinflammatory and immunosuppressive drugs are listed in Table I.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 16.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Bibliography

General References

  • Bonta, I. L., Bray, M. A., and Parnham, M. J., eds., 1985, Handbook of Inflammation, Elsevier, Amsterdam. A useful source on the mechanisms of inflammation.

    Google Scholar 

  • Drug Evaluations, 6th ed., 1986, American Medical Association, Chicago. A useful general source on the treatments of inflammation.

    Google Scholar 

  • Espinosa, L., ed., 1988, Infections in the Rheumatic Diseases, Grune & Stratton, New York. A text on the role of infection in rheumatoid arthritis and the reactive arthritides.

    Google Scholar 

  • McCarthy, D. J., ed., 1985, Arthritis, Lea & Febiger, Philadelphia. A classic reference for the rheumatologist.

    Google Scholar 

  • Roth, S. M., ed., 1985, Rheumatic Therapeutics, McGraw-Hill, New York. A useful general source on the treatment of rheumatic disease.

    Google Scholar 

Specific References

  • Dunn, M., and Weissman, G., eds., 1987, Arachidonic acid metabolism and inflammation: Therapeutic implications, Drugs 33, Suppl. 1:1. A collection of seven reviews of arachidonic acid metabolites and NSAIDs in physiologic and pathologic processes.

    Google Scholar 

  • Hench, P. S., Kendall, E. D., Slocumb, C. H., and Polley, H. E, 1949, The effect of a hormone of the adrenal cortex (17-hydroxy-ll-dehydrocorticosterone; compound E) and of pituitary adrenocorticotropic hormone on rheumatoid arthritis, Proc. Staff Meet. Mayo Clin.24:181. Classic paper describing effects of ACTH and glucocorticoids on arthritis symptoms.

    CAS  Google Scholar 

  • Lipsky, P. E., 1983, Immunopharmacology of remission-inducing drugs in rheumatoid arthritis, in: Advances in Immunopharmacology 2 (J. W. Hadden, L. Chedid, P. Dukor, F. Spreaflco, and D. Willoughby, eds.), Pergamon Press, Elmsford, NY, pp. 345–350. A review of new approaches to the treatment of rheumatoid arthritis.

    Google Scholar 

  • Oates, J. A., Fitzgerald, G. A., Branch, R. A., Jackson, E. K., Knapp, H. R., and Roberts, L. J., II, 1988, Clinical implications of prostaglandin and thromboxane formation, N. Engl. J. Med.319:689–761. A review of the physiological actions of eicosanoids and effects of NSAIDs.

    Article  PubMed  CAS  Google Scholar 

  • Talal, N., and Hadden, J. W., 1985, Hormones, immunomodulating drugs and autoimmunity, in: Handbook of Inflammation, Volume 5 (I. L. Bonta, M. A. Bray, and M. J. Parnham, eds.), Elsevier, Amsterdam, p. 335–345. A review of new antirheumatic agents.

    Google Scholar 

  • Vane, J., 1971, Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs, Nature New Biol.231:232–235. Classic paper describing aspirin inhibition of cyclooxygenase.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1996 Plenum Press, New York

About this chapter

Cite this chapter

Hadden, J.W., Coffey, R.G. (1996). Drugs for the Treatment of Inflammatory and Autoimmune Disease. In: Hadden, J.W., Szentivanyi, A. (eds) Immunopharmacology Reviews Volume 2. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-0349-7_2

Download citation

  • DOI: https://doi.org/10.1007/978-1-4613-0349-7_2

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-8010-8

  • Online ISBN: 978-1-4613-0349-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics